DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn’s disease: interim results of the CAPE registryD Turner,S Koletzko,H Winter,R Baldassano,M Dubinsky,W Faubion,J Hyams, S Kugathasan,J Rosh,J Escher,A Griffiths,J Kierkus,R Russell,G Heap, D Arikan, V Kuehnl,J Petersson,A Robinson, F RuemmeleJournal of Crohns & Colitis（2018）引用 0|浏览30暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
